Safety and Compliance of Taking Mesalamine Once a Day in Pediatric Patients
Status:
Terminated
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
To determine whether once a day administration of Mesalamine is at least as safe and
efficacious and administration of multiple doses a day in preventing clinical relapse of
ulcerative colitis in children and adolescence.